Healthcare
Pharmaceutical
Business Services

McKesson

$120.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.87 (-1.53%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell McKesson and other stocks, options, ETFs, and crypto commission-free!

About

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the McKesson Distribution Solutions and McKesson Technology Solutions business segments. Read More The McKesson Distribution Solutions segment istributes brand, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs and other healthcare-related products worldwide. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Wilmington, DE.

Employees
78,000
Headquarters
San Francisco, California
Founded
1833
Market Cap
23.16B
Price-Earnings Ratio
Dividend Yield
0.92
Average Volume
1.68M
High Today
$122.69
Low Today
$120.43
Open Price
$122.36
Volume
348.55K
52 Week High
$160.84
52 Week Low
$106.11

Collections

Healthcare
Pharmaceutical
Business Services
Medical
Technology
Retail
Information Technology
Finance

News

Seeking AlphaMar 19

Keep On Buying McKesson

McKesson (MCK) dominates pharmaceutical distribution along with its peers Cardinal Health (CAH) and AmerisourceBergen (ABC). The oligopoly offers investors strong barriers to entry, and in McKesson’s case, adequate value creation to consider an investment.

69
TradingNewsNowMar 19

Long or Short: McKesson Corporation (NYSE: MCK)

McKesson Corporation is part of the healthcare sector and trades as part of the medical distribution industry. The company CEO is John H. Hammergren. McKesson Corp provides medicines, pharmaceutical supplies, information and care management products and services across the healthcare industry. It operates with two segments namely McKesson Distribution Solutions and McKesson Technology Solutions. Previous Intraday Trading Performance: The MCK stock showed a previous change of 1.77% with an open at 119.81 a...

23
Seeking AlphaMar 17

McKesson: Don't Sell Into Pending Upmove

Our McKesson (NYSE:MCK) position has been a laggard in our portfolio for quite some time now. Despite managing to rally aggressively out of its December low last year, shares came right back down towards the $110 mark before printing what we hope will end up being a final bottom here. The problem though with depressed stocks is that they can take their time to return to rallying mode. McKesson at present trades with a book multiple of 2.5 and a cash flow multiple of 7.5. These numbers are significantly belo...

6

Earnings

$2.46
$2.84
$3.22
$3.60
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
Actual
Expected May 23, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.